These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1512711)
41. Nucleotide sequence of dihydrofolate reductase genes from trimethoprim-resistant mutants of Escherichia coli. Evidence that dihydrofolate reductase interacts with another essential gene product. Smith DR; Calvo JM Mol Gen Genet; 1982; 187(1):72-8. PubMed ID: 6761546 [TBL] [Abstract][Full Text] [Related]
42. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Brown PD; Freeman A; Foxman B Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994 [TBL] [Abstract][Full Text] [Related]
43. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. Murray BE; Rensimer ER; DuPont HL N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of the type I and type II DHFR genes in trimethoprim-resistant urinary isolates of Escherichia coli from Greece. Tsakris A; Johnson AP; Legakis NJ; Tzouvelekis LS J Antimicrob Chemother; 1993 May; 31(5):665-71. PubMed ID: 8392996 [TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs. Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537 [TBL] [Abstract][Full Text] [Related]
46. Plasmid pDGO100 contains a second integron with the trimethoprim resistance gene dfrA7 as the inserted cassette. Burnside JM; Groot Obbink DJ Plasmid; 1996 Jan; 35(1):67-70. PubMed ID: 8693029 [TBL] [Abstract][Full Text] [Related]
47. Sulphonamide resistance gene sul3 found in Escherichia coli isolates from human sources. Grape M; Sundström L; Kronvall G J Antimicrob Chemother; 2003 Dec; 52(6):1022-4. PubMed ID: 14585855 [TBL] [Abstract][Full Text] [Related]
48. In vivo R-plasmid transfer in a patient with a mixed infection of shigella dysentery. Bratoeva MP; John JF Epidemiol Infect; 1994 Apr; 112(2):247-52. PubMed ID: 8149999 [TBL] [Abstract][Full Text] [Related]
50. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole. Gupta KC; Desai NK; Paul T; Sheth UK Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):536-7. PubMed ID: 7228448 [TBL] [Abstract][Full Text] [Related]
51. The comeback of trimethoprim in France. Caron F; Wehrle V; Etienne M Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762 [TBL] [Abstract][Full Text] [Related]
52. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram. Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821 [TBL] [Abstract][Full Text] [Related]
53. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. Blahna MT; Zalewski CA; Reuer J; Kahlmeter G; Foxman B; Marrs CF J Antimicrob Chemother; 2006 Apr; 57(4):666-72. PubMed ID: 16464890 [TBL] [Abstract][Full Text] [Related]
54. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt. Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681 [TBL] [Abstract][Full Text] [Related]
55. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. Giamarellos-Bourboulis EJ; Karnesis L; Giamarellou H Diagn Microbiol Infect Dis; 2002 Nov; 44(3):259-63. PubMed ID: 12493173 [TBL] [Abstract][Full Text] [Related]
56. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus. Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801 [TBL] [Abstract][Full Text] [Related]
57. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria. Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064 [TBL] [Abstract][Full Text] [Related]
58. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. Greenwood D; O'Grady F J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036 [TBL] [Abstract][Full Text] [Related]
59. Genetic structures associated with spread of the type Ia trimethoprim-resistant dihydrofolate reductase gene amongst Escherichia coli strains isolated in the Nottingham area of the United Kingdom. Towner KJ; Brennan A; Zhang Y; Holtham CA; Brough JL; Carter GI J Antimicrob Chemother; 1994 Jan; 33(1):25-32. PubMed ID: 8157570 [TBL] [Abstract][Full Text] [Related]
60. Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. Prado D; López E; Liu H; Devoto S; Woloj M; Contrini M; Murray BE; Gómez H; Cleary TG Pediatr Infect Dis J; 1992 Aug; 11(8):644-7. PubMed ID: 1523076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]